Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-001476

Chief Financial Officer sold 8,333 shares at $11.98 ($99,829)

  • Chief Financial Officer acquired 85,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2019-01-01 Grant or award +85,000 395,815 D
Myszkowski Kenneth Allen Chief Financial Officer 2019-01-02 Sale −8,333 $11.98 $99,829 387,482 D
Open-market sales · 8,333 sh · avg $11.98 · $99,829
Loading xslF345X03/doc4.xml…